proteins for the treatment of respiratory diseases such as COPD, and other autoimmune/inflammatory diseases (AAIDs). The approach combines bioinformatics, structure-based protein engineering and proprietary assays to develop novel, differentiated...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to ProtAffin AG granted patent in EU for CellJammer(R) discovery technology
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account